Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$26.90−0.55 (-2.00%)
Close on Nov 18, 2026Market cap $1.30BP/E –Yield –
Nanobiotix revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was €32.59M. The highest annual figure on record is €36.21M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €32.59M | – |
| FY2024 | Dec 31, 2024 | -€7.19M | -119.9% |
| FY2023 | Dec 31, 2023 | €36.21M | +658.1% |
| FY2022 | Dec 31, 2022 | €4.78M | +80.4% |
| FY2021 | Dec 31, 2021 | €2.65M | +5.4% |
| FY2020 | Dec 31, 2020 | €2.51M | -1.1% |
| FY2019 | Dec 31, 2019 | €2.54M | -27.0% |
| FY2018 | Dec 31, 2018 | €3.48M | – |
See a number that looks wrong?